Finance

Lists
Why is ABTT34 down 2,67%?
Dive Deeper
ABTT34:BVMF
Abbott Laboratories BDR
40,76 BRL
-2,67%
(-1,12) 1D
6-окт., 16:47:27 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ABTT34...
Open
41,66 BRL
High
41,66 BRL
Low
40,77 BRL
Mkt. cap
165,44 млд
Avg. vol.
260,00
Volume
486,00
52-wk high
60,34 BRL
52-wk low
33,34 BRL
Shares outstanding
1,73 млд
No. of employees
115 миң
Open
41,66 BRL
High
41,66 BRL
Low
40,77 BRL
Mkt. cap
165,44 млд
Avg. vol.
260,00
Volume
486,00
52-wk high
60,34 BRL
52-wk low
33,34 BRL
Shares outstanding
1,73 млд
No. of employees
115 миң
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories BDR
CEORobert B. Ford
Employees115 миң
Founded1888
HeadquartersЧикаго, Иллинойс, Америка Кошмо Штаттары
SectorMedical device
Websiteabbott.com
Last report
2026-ж., 16-июл.
Fiscal period
Q2 2026
EPS / Est. (USD)
1,31 USD / 1,28 USD
+2,61%beat
Revenue / Est. (USD)
12,59 млд / 12,52 млд
+0,61%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
11,37 млд
11,46 млд
11,16 млд
12,59 млд
Cost of goods sold
5,08 млд
4,91 млд
4,89 млд
5,32 млд
Cost of revenue
5,08 млд
4,91 млд
4,89 млд
5,32 млд
Research and development expenses
766,00 млн
720,00 млн
767,00 млн
892,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,90 млд
2,93 млд
3,58 млд
3,87 млд
Operating expense
4,09 млд
4,07 млд
4,77 млд
5,42 млд
Total operating expenses
9,16 млд
8,98 млд
9,66 млд
10,74 млд
Operating income
2,20 млд
2,48 млд
1,50 млд
1,85 млд
Other non operating income
2,00 млн
-15,00 млн
-
-25,00 млн
EBT including unusual items
2,18 млд
2,36 млд
1,45 млд
1,52 млд
EBT excluding unusual items
2,18 млд
2,44 млд
1,45 млд
1,52 млд
Income tax expense
536,00 млн
582,00 млн
372,00 млн
596,00 млн
Effective tax rate
24,59%
24,68%
25,67%
39,11%
Other operating expenses
-
-
-
-
Net income
1,64 млд
1,78 млд
1,08 млд
928,00 млн
Net profit margin
14,46%
15,50%
9,65%
7,37%
Earnings per share
1,30
1,50
1,15
1,31
Interest and investment income
77,00 млн
78,00 млн
106,00 млн
52,00 млн
Interest expense
-121,00 млн
-120,00 млн
-174,00 млн
-351,00 млн
Net interest expenses
-44,00 млн
-42,00 млн
-68,00 млн
-299,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,00 млд
3,27 млд
2,31 млд
2,91 млд
Gain or loss from assets sale
-
65,00 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору